Ronil A. Patel is Chief Business Officer of Ocuphire Pharma, Inc.. Currently has a direct ownership of 90,714 shares of OCUP, which is worth approximately $105,228. The most recent transaction as insider was on Jan 10, 2024, when has been sold 1,282 shares (Common Stock) at a price of $3.27 per share, resulting in proceeds of $4,192. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 90.7K
0% 3M change
114.43% 12M change
Total Value Held $105,228

Ronil A. Patel Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 10 2024
SELL
Payment of exercise price or tax liability
$4,192 $3.27 p/Share
1,282 Reduced 1.39%
90,714 Common Stock
Dec 01 2023
BUY
Grant, award, or other acquisition
-
49,692 Added 35.07%
91,996 Common Stock
Apr 24 2023
BUY
Grant, award, or other acquisition
-
20,000 Added 32.1%
42,304 Common Stock
RAP

Ronil A. Patel

Chief Business Officer
Farmington Hills, MI

Track Institutional and Insider Activities on OCUP

Follow Ocuphire Pharma, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells OCUP shares.

Notify only if

Insider Trading

Get notified when an Ocuphire Pharma, Inc. insider buys or sells OCUP shares.

Notify only if

News

Receive news related to Ocuphire Pharma, Inc.

Track Activities on OCUP